help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noguchi, T.
Right arrow Articles by Nagata, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noguchi, T.
Right arrow Articles by Nagata, K.

Am. J. Respir. Crit. Care Med., Vol 155, No. 4, 04 1997, 1316-1322.

Heat shock protein 72 level decreases during sleep in patients with obstructive sleep apnea syndrome

T Noguchi, K Chin, M Ohi, H Kita, N Otsuka, T Tsuboi, M Satoh, A Nakai, K Kuno and K Nagata
Department of Clinical Physiology, Chest Disease Research Institute, Kyoto University, Sakyo-ku, Japan.

Patients with obstructive sleep apnea syndrome (OSAS) suffer from stresses related to repetitive apneas during sleep. To examine whether the level of 72 kDa heat shock protein (HSP72) increases during sleep, 11 OSAS patients (apnea-hypopnea index: 63.5 +/- 36.1, mean +/- SD) underwent polysomnography and their peripheral blood mononuclear cells (PBMC) were isolated before, during, and after sleep. HSP72 level was determined by Western blotting and hsp72 mRNA level was quantified by Northern blotting. Nine normal subjects without OSAS were examined as normal controls. HSP72 level decreased progressively during sleep and its level at 8:00 A.M. was 78.0 +/- 17.5% of that at 8:00 P.M. (p < 0.01). No such decrease was seen in normal subjects. When OSAS patients received nasal continuous positive airway pressure (NCPAP) therapy, HSP72 level did not decrease significantly. In untreated OSAS patients, hsp72 mRNA level decreased during sleep (p < 0.01). When OSAS patients were treated with NCPAP therapy, the decrease in hsp72 mRNA level was not observed. HSP72 level before sleep in OSAS patients was higher than that in normal subjects (p < 0.01). We concluded that repetitive apneas caused high HSP72 level before sleep in OSAS patients and that NCPAP therapy had significant effect on HSP72 levels during sleep.


This article has been cited by other articles:


Home page
ChestHome page
T. Nakamura, K. Chin, R. Hosokawa, K. Takahashi, K. Sumi, M. Ohi, and M. Mishima
Corrected QT Dispersion and Cardiac Sympathetic Function in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome
Chest, June 1, 2004; 125(6): 2107 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. DURAND, M. BACHELET, F. BRUNET, M. J. RICHARD, J.-F. DHAINAUT, J. DALL'AVA, and B. S. POLLA
Inducibility of the 70 kD Heat Shock Protein in Peripheral Blood Monocytes Is Decreased in Human Acute Respiratory Distress Syndrome and Recovers Over Time
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 286 - 292.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
E. Ohga, T. Nagase, T. Tomita, S. Teramoto, T. Matsuse, H. Katayama, and Y. Ouchi
Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome
J Appl Physiol, July 1, 1999; 87(1): 10 - 14.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008